SemaThera is a spin-off company focusing on SEMA 3A inhibitors in the treatment of ocular diseases.
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
GrayBug is a biotechnology company developing technologies to treat eye diseases.
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.
PellePharm, Inc. operates in the biotechnology industry.
Montreal-West, CA HQ
Cambridge, US HQ
Redwood City, US HQ
Roseville, US HQ
Menlo Park, US HQ
Twitter followers1.9 k
Alexa Website Rank
Alexa Website RankN/A
Alexa Website Rank1054401
Alexa Website Rank796349
Alexa Website Rank438444
Alexa Website Rank1028454
Latest funding round
Latest funding round$ 1m (over 2 years ago)
Latest funding round$ 3.2m (about 6 years ago)
Latest funding round$ 80m (29 days ago)
Latest funding round$ 25m (about 5 years ago)
Latest funding round$ 70m (10 months ago)
Total funding raised
Total funding raised$ 1m
Total funding raised$ 3.2m
Total funding raised$ 128.5m
Total funding raised$ 27.8m
Total funding raised$ 81.4m